Therapeuticsmd
TXMD
Therapeuticsmd (TXMD) earnings history
Most recent quarter
- Fiscal period
- Q3 2024
- Period end
- Sep 30, 2024
- EPS actual
- −$0.05
- EPS estimate
- $0.04
- EPS surprise
- −225.00%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $2.3M
- Reported
- Nov 12, 2024
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2024 | Nov 12, 2024 | $0.04 | −$0.05 | −225.00% | $0.00 | SEC |
| Q2 2024 | Aug 12, 2024 | $0.03 | −$0.09 | −400.00% | $0.00 | SEC |
| Q1 2024 | May 10, 2024 | $0.03 | −$0.07 | −333.33% | $0.00 | SEC |
| Q4 2023 | Mar 29, 2024 | −$0.13 | −$0.13 | +0.00% | $0.00 | SEC |
| Q3 2023 | Nov 14, 2023 | −$0.15 | −$0.13 | +13.33% | $0.00 | SEC |
| Q2 2023 | Aug 14, 2023 | −$0.07 | −$0.24 | −242.86% | $0.00 | SEC |
| Q1 2023 | May 15, 2023 | $0.06 | −$0.24 | −500.00% | $400,000.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$0.57 | −$3.13 | −449.12% | $20.9M | SEC |
| Q2 2022 | Aug 15, 2022 | −$3.04 | $12.39 | +507.57% | $28.5M | SEC |
| Q1 2022 | May 16, 2022 | −$4.00 | −$5.69 | −42.25% | $18.9M | SEC |
| Q4 2021 | Mar 10, 2022 | −$3.83 | −$5.00 | −30.44% | $18.7M | SEC |
| Q3 2021 | Nov 12, 2021 | −$5.00 | −$5.50 | −10.00% | $24.5M | SEC |
| Q2 2021 | Aug 4, 2021 | −$5.50 | −$5.50 | +0.00% | $23.0M | SEC |
| Q1 2021 | May 6, 2021 | −$6.13 | −$5.50 | +10.20% | $19.6M | SEC |
| Q4 2020 | Mar 2, 2021 | −$5.30 | −$7.50 | −41.51% | $22.6M | — |
| Q3 2020 | Nov 9, 2020 | −$6.71 | −$6.00 | +10.64% | $19.3M | — |
| Q2 2020 | Aug 6, 2020 | −$8.31 | −$9.50 | −14.29% | $10.7M | — |
| Q1 2020 | May 6, 2020 | −$9.51 | −$10.50 | −10.44% | $12.3M | — |
Quarterly revenue
Frequently asked questions
When did Therapeuticsmd (TXMD) last report earnings?
Therapeuticsmd last reported on Nov 12, 2024, covering fiscal Q3 2024.
Did TXMD beat earnings estimates?
No. Therapeuticsmd reported EPS of −$0.05 for Q3 2024 against a $0.04 estimate — a 225.00% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.